SAM #NOI-CC-OLAO-26-006399

Sole Source Procurement of ORTHO VISION Analyzer System for NIH Clinical Center

NIH Clinical Center is seeking to procure an ORTHO VISION Analyzer system and related accessories for pretransfusion blood testing via a sole source contract with Quidel-Ortho Clinical Diagnostics. - Procurement Details: - Sole source award to Quidel-Ortho Clinical Diagnostics (QuidelOrtho Sales Company, LLC) - Equipment includes: - 1 ORTHO VISION Analyzer (Product Code 6904577) - 1 ORTHO VISION Table (Product Code 6904701) - 1 Lexmark Printer (Product Code 6986685) - 1 HBS Validation and Competency Kit (Product Code H2010) - Includes a 1-year standard service warranty (Monday-Friday, 8AM-5PM) - Maintenance and warranty repair services required for reliability and compatibility with liquid nitrogen supply cylinders - Purpose and Requirements: - Supports pretransfusion testing for blood grouping and antibody detection - Fully automated workflow to minimize wait times and reduce human error - Ensures transfusion safety and compatibility - Contract Value and Term: - Estimated contract value: $92,485.66 - 12-month term starting from quote date (May 1, 2026) - Place of Performance: - NIH Clinical Center, Department of Transfusion Medicine, Bethesda, MD - Commercial Opportunity: - Sole source justification: Only Quidel-Ortho Clinical Diagnostics can meet NIH's requirements for this equipment - No competing vendors or products identified in the notice - Key OEM: - Quidel-Ortho Clinical Diagnostics (QuidelOrtho Sales Company, LLC) - Potential Competitors (for similar future requirements): - Abbott Laboratories, Bio-Rad Laboratories, Beckman Coulter, Siemens Healthineers

Description

This is a Notice of Intent, not a request for proposal.  The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: QuidelOrtho Sales Company, LLC.

Acquistion Description:

DTM uses Quidel-Ortho Clinical Diagnostics, Inc. technology to perform pretransfusion testing for blood grouping and antibody detection. It is a critical instrument in determining red blood cell compatibility for transfusion and offers the option of a fully automated workflow. The system minimizes wait time and reduces human error in support of improved transfusion safety. 

The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.  All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-006399) by 12:00 PM eastern standard time on 05/29/2026 to: valerie.gregorio@nih.gov.

All responses received by the closing date of this synopsis will be considered by the Government.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

View original listing